GlassScriptPhysician profile
Dale S Johnson
NPI 1730344433
$4,865.52
in general payments reported to CMS, 2019-2025
13 companies · $502 in 2025
The $502 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $69.14 · 2021: $568 · 2022: $817 · 2023: $352 · 2024: $1,051 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731 · Entertainment: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.74 |
| Entertainment | $174.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,098.71 | 2019-2025 | Myday Contact Lens, Cvi Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $997.21 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $850.02 | 2022-2025 | Infuse |
| Alcon Vision LLC | $830.22 | 2019-2025 | Dailies Total1, Clareon, Precision7 |
| Optos, INC. | $328.46 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lombart Brothers, INC. | $138.32 | 2024 | Opd-III |
| Amgen INC. | $122.35 | 2024 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $122.03 | 2019 | |
| Lkc Technologies, INC. | $117.62 | 2024 | |
| Optovue, INC. | $100.36 | 2019 | |
| Maculogix, INC. | $75.98 | 2019-2020 | |
| Glaukos Corporation | $44.24 | 2024 | Radius |
| Visionix USA, INC | $40.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.